U.S. v. SAGE PHARMACEUTICALS, INC.

No. 99-30425.

210 F.3d 475 (2000)

UNITED STATES of America, Plaintiff-Appellant, v. SAGE PHARMACEUTICALS, INC., Jivn Ren Chen, Defendants-Appellees.

United States Court of Appeals, Fifth Circuit.

April 20, 2000.


Attorney(s) appearing for the Case

H. Thomas Byron, III (argued), Mark Bernard Stern, U.S. Dept. of Justice, Civil Div., Appellate Staff, Washington, DC, John Robert Halliburton, Shreveport, LA, for Plaintiff-Appellant.

Jerald R. Harper, Nicole Montagnet Smith (argued), Cook, Yancey, King & Galloway, Shreveport, LA, for Defendants-Appellees.

Before HIGGINBOTHAM and PARKER, Circuit Judges, and JACK, District Judge.


JANIS GRAHAM JACK, District Judge:

This is an enforcement action brought by the United States against Sage Pharmaceuticals, Inc., a manufacturer of prescription and over-the-counter drugs, and its president, Jivn Ren Chen (collectively, Sage). The United States sought to enjoin the distribution of adulterated drugs and unapproved new drugs in violation of the Federal Food, Drug, and Cosmetic Act (FDCA).1 Following a three day bench trial...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases